Founders Advises Specialty Pharmacy in Recent Deal
Founders Investment Banking is pleased to announce that a prominent 340B program management organization has purchased substantially all of the stock of a URAC accredited specialty pharmacy focused on providing care to patients with chronic or difficult to treat conditions across a wide spectrum of therapies. The Company fills prescriptions nationwide, and had experienced average annual growth of over 121% since being founded in 2011. Shareholders were exclusively advised by Principals of Founders Investment Banking. The transaction was led by Zane Tarence of Founders. Due to competitive sensitivities, the acquirers have requested that some of the parties and terms of the transaction remain confidential.
“Founders provided incredible service by first listening to our goals, and from there putting in a game plan to identify the right partner who could help continue the Company’s growth trajectory, while relieving some of the pain points that come with such quick growth,” said President and CEO of the selling company. “The Founders team did an excellent job helping me find a great partner to move forward with and close the deal. It was a great relationship and I’m grateful for their assistance.”
Zane Tarence, Managing Director at Founders Investment Banking, noted that “The selling specialty pharmacy’s President and CEO was one of the most impressive entrepreneurs we have had the privilege of working with. The culture built to provide excellent quality and service to both patients and physicians was admirable, especially in an industry experiencing such rapid change. We are excited for the future success of the company. The purchasing company is an equally impressive organization and an excellent partner for the specialty pharmacy to continue forward with. We look forward to the synergies and strategic benefits that will result from the partnership.”
About Founders Investment Banking, LLC
Founders Investment Banking is a merger and acquisition advisory firm based in Birmingham, Alabama. Its team’s proven expertise and process-based solutions help companies and business owners access capital and prepare for and execute liquidity events to achieve specific financial goals. The firm focuses on oil and gas, industrial, and manufacturing clients located across the Southeast, and technology and specialty pharmacy clients across the United States. For more information, visit www.foundersib.com. In order to provide securities-related services discussed herein, certain principals of Founders are licensed with M & A Securities Group, Inc. or Founders M&A Advisory, LLC, both members of member FINRA & SiPC. M&A Securities Group and Founders are unaffiliated entities. Founders M&A Advisory is a wholly-owned subsidiary of Founders. The testimonial presented herein does not guarantee future performance or success.